Search results
Results from the WOW.Com Content Network
Respiratory syncytial virus (RSV), [a] also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. [2] Its name is derived from the large cells known as syncytia that form when infected cells fuse. [2] [3]
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. [1] RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. [2] The RSV vaccines Arexvy , [3] Abrysvo , [4] and Mresvia [5] are approved for medical use in the United States.
In the 1950s, improvements in virus isolation and detection methods resulted in the discovery of several important human viruses including varicella zoster virus, [63] the paramyxoviruses [64] – which include measles virus [65] and respiratory syncytial virus [64] – and the rhinoviruses that cause the common cold. [66]
Flu and cold season has come around again. ... RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually causing mild, cold-like ...
Respiratory syncytial virus, a.k.a. RSV, is a common respiratory virus that usually causes mild, cold-like symptoms, according to the Centers for Disease Control and Prevention(CDC).
The CDC estimates between 58,000 and 80,000 U.S. children under 5 are hospitalized with RSV every year, resulting in 100 to 300 U.S. kids under 5 dying, though other estimates are much higher.An ...
Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. [2] [4] It is recommended for infants at high-risk for RSV due to conditions such as prematurity or other medical problems including heart or lung ...
Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). [10] [11] It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor [6] that is designed to bind to the fusion protein on the surface of the RSV virus.